Belimumab Use, Clinical Outcomes and Glucocorticoid Reduction in Patients with Systemic Lupus Erythematosus Receiving Belimumab in Clinical Practice Settings: Results from the OBSErve Canada Study
Rheumatology international（2017）
关键词
Lupus erythematosus,systemic,B-cell activating factor,Observational study,Glucocorticoids,Disease progression,Rheumatology
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要